OA10204A - Squalene synthetase inhibitors - Google Patents
Squalene synthetase inhibitors Download PDFInfo
- Publication number
- OA10204A OA10204A OA60759A OA60759A OA10204A OA 10204 A OA10204 A OA 10204A OA 60759 A OA60759 A OA 60759A OA 60759 A OA60759 A OA 60759A OA 10204 A OA10204 A OA 10204A
- Authority
- OA
- OAPI
- Prior art keywords
- neopentyl
- compound
- oxo
- chloro
- trans
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D267/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D267/02—Seven-membered rings
- C07D267/08—Seven-membered rings having the hetero atoms in positions 1 and 4
- C07D267/12—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D267/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D267/02—Seven-membered rings
- C07D267/08—Seven-membered rings having the hetero atoms in positions 1 and 4
- C07D267/12—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D267/14—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with one six-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D281/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D281/02—Seven-membered rings
- C07D281/04—Seven-membered rings having the hetero atoms in positions 1 and 4
- C07D281/08—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D281/10—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with one six-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Communicable Diseases (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Obesity (AREA)
- Hospice & Palliative Care (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Psychiatry (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Steroid Compounds (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US36271394A | 1994-12-23 | 1994-12-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| OA10204A true OA10204A (en) | 1996-12-18 |
Family
ID=23427229
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| OA60759A OA10204A (en) | 1994-12-23 | 1995-12-22 | Squalene synthetase inhibitors |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US5770594A (is) |
| JP (1) | JPH10500702A (is) |
| KR (1) | KR960022510A (is) |
| CN (1) | CN1133287A (is) |
| AU (1) | AU4067795A (is) |
| BG (1) | BG100248A (is) |
| BR (1) | BR9505995A (is) |
| CA (1) | CA2207772A1 (is) |
| CZ (1) | CZ344795A3 (is) |
| FI (1) | FI972696A0 (is) |
| GT (1) | GT199500058A (is) |
| HU (1) | HUT74672A (is) |
| IL (1) | IL116399A0 (is) |
| IS (1) | IS4312A (is) |
| LV (1) | LV11325B (is) |
| MA (1) | MA23746A1 (is) |
| MX (1) | MX9704683A (is) |
| NO (1) | NO955288L (is) |
| OA (1) | OA10204A (is) |
| PE (1) | PE60096A1 (is) |
| PL (1) | PL311997A1 (is) |
| SI (1) | SI9500393A (is) |
| SK (1) | SK158795A3 (is) |
| TN (1) | TNSN95133A1 (is) |
| TR (1) | TR199501644A2 (is) |
| WO (1) | WO1996020184A1 (is) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5965553A (en) * | 1996-06-20 | 1999-10-12 | Pfizer Inc. | Squalene synthetase inhibitors |
| WO1997048701A1 (en) * | 1996-06-20 | 1997-12-24 | Pfizer Inc. | 4,1-benzoxazepines or 4,1-benzothiazepines and their use as squalene synthetase inhibitors |
| DE19716120A1 (de) * | 1997-04-17 | 1998-10-22 | Europ Lab Molekularbiolog | Verwendung von cholesterinsenkenden Mitteln |
| US20060141036A1 (en) * | 1997-12-12 | 2006-06-29 | Andrx Labs Llc | HMG-CoA reductase inhibitor extended release formulation |
| US6403576B1 (en) * | 1998-08-24 | 2002-06-11 | The United States Of America As Represented By The Secretary Of The Navy | Antifungal and antiparasitic compounds |
| US20020054871A1 (en) * | 1999-04-12 | 2002-05-09 | Yadong Huang | Methods and compositions for use in the treatment of hyperlipidemia |
| US20020107173A1 (en) * | 1999-11-04 | 2002-08-08 | Lawrence Friedhoff | Method of treating amyloid beta precursor disorders |
| CA2389973A1 (en) * | 1999-11-04 | 2001-05-10 | Andrx Corporation | Method of treating amyloid beta precursor disorders |
| ATE434615T1 (de) * | 2000-11-21 | 2009-07-15 | Janssen Pharmaceutica Nv | Farnesyltransferase hemmende benzoheterocyclische derivate |
| WO2008121602A1 (en) * | 2007-03-29 | 2008-10-09 | Smithkline Beecham Corporation | Chemical compounds |
| GB0803747D0 (en) * | 2008-02-29 | 2008-04-09 | Martin | Enzyme and receptor modulation |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG82630A1 (en) * | 1992-04-20 | 2001-08-21 | Takeda Chemical Industries Ltd | 4,1-benzoxazepin derivatives and their use |
| AU678503B2 (en) * | 1993-09-24 | 1997-05-29 | Takeda Chemical Industries Ltd. | Condensed heterocyclic compounds and their use as squalene synthetase inhibitors |
| EP0782451A1 (en) * | 1994-09-20 | 1997-07-09 | Pfizer Inc. | Combination of a cholesterol absorption inhibitor and a cholesterol synthesis inhibitor |
-
1995
- 1995-06-02 FI FI972696A patent/FI972696A0/fi not_active Application Discontinuation
- 1995-06-02 US US08/860,155 patent/US5770594A/en not_active Expired - Fee Related
- 1995-06-02 MX MX9704683A patent/MX9704683A/es not_active IP Right Cessation
- 1995-06-02 CA CA002207772A patent/CA2207772A1/en not_active Abandoned
- 1995-06-02 JP JP8520314A patent/JPH10500702A/ja active Pending
- 1995-06-02 WO PCT/IB1995/000424 patent/WO1996020184A1/en not_active Ceased
- 1995-06-02 BR BR9505995A patent/BR9505995A/pt not_active Application Discontinuation
- 1995-06-02 SK SK1587-95A patent/SK158795A3/sk unknown
- 1995-12-13 GT GT199500058A patent/GT199500058A/es unknown
- 1995-12-14 IL IL11639995A patent/IL116399A0/xx unknown
- 1995-12-18 MA MA24097A patent/MA23746A1/fr unknown
- 1995-12-18 PE PE1995287390A patent/PE60096A1/es not_active Application Discontinuation
- 1995-12-19 IS IS4312A patent/IS4312A/is unknown
- 1995-12-21 LV LVP-95-379A patent/LV11325B/en unknown
- 1995-12-21 TN TNTNSN95133A patent/TNSN95133A1/fr unknown
- 1995-12-21 BG BG100248A patent/BG100248A/xx unknown
- 1995-12-21 PL PL95311997A patent/PL311997A1/xx unknown
- 1995-12-22 CN CN95120143A patent/CN1133287A/zh active Pending
- 1995-12-22 NO NO955288A patent/NO955288L/no unknown
- 1995-12-22 TR TR95/01644A patent/TR199501644A2/xx unknown
- 1995-12-22 HU HU9503783A patent/HUT74672A/hu unknown
- 1995-12-22 CZ CZ953447A patent/CZ344795A3/cs unknown
- 1995-12-22 OA OA60759A patent/OA10204A/en unknown
- 1995-12-22 SI SI9500393A patent/SI9500393A/sl unknown
- 1995-12-22 AU AU40677/95A patent/AU4067795A/en not_active Abandoned
- 1995-12-22 KR KR1019950054933A patent/KR960022510A/ko not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| NO955288L (no) | 1996-06-24 |
| NO955288D0 (no) | 1995-12-22 |
| LV11325A (lv) | 1996-06-20 |
| US5770594A (en) | 1998-06-23 |
| PL311997A1 (en) | 1996-06-24 |
| IL116399A0 (en) | 1996-03-31 |
| IS4312A (is) | 1996-06-24 |
| HU9503783D0 (en) | 1996-04-29 |
| JPH10500702A (ja) | 1998-01-20 |
| SK158795A3 (en) | 1997-01-08 |
| AU4067795A (en) | 1996-07-04 |
| GT199500058A (es) | 1997-06-05 |
| BR9505995A (pt) | 1997-12-23 |
| BG100248A (bg) | 1996-07-31 |
| CN1133287A (zh) | 1996-10-16 |
| FI972696A7 (fi) | 1997-06-23 |
| MX9704683A (es) | 1997-09-30 |
| CA2207772A1 (en) | 1996-07-04 |
| TNSN95133A1 (fr) | 1996-02-06 |
| LV11325B (en) | 1997-02-20 |
| PE60096A1 (es) | 1996-12-28 |
| KR960022510A (ko) | 1996-07-18 |
| SI9500393A (en) | 1997-04-30 |
| TR199501644A2 (tr) | 1996-11-21 |
| CZ344795A3 (en) | 1996-09-11 |
| HUT74672A (en) | 1997-01-28 |
| FI972696L (fi) | 1997-06-23 |
| FI972696A0 (fi) | 1997-06-23 |
| MA23746A1 (fr) | 1996-07-01 |
| WO1996020184A1 (en) | 1996-07-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5203361B2 (ja) | プロリルヒドロキシラーゼ阻害剤 | |
| US8101615B2 (en) | 1,4-diaryl-dihydropyrimidin-2-ones and their use as human neutrophil elastase inhibitors | |
| CN1210268C (zh) | ((环)烷基取代的)-γ-氨基丁酸衍生物(=GABA类似物),其制备和在治疗神经病中的用途 | |
| US6677333B1 (en) | 2H-phthalazin-1-one derivatives and drug containing its derivatives as active ingredient | |
| CA2562075C (en) | Substituted thiazole and pyrimidine derivatives as melanocortin receptor modulators | |
| BRPI0806566A2 (pt) | Derivados de glicina n-substituída: inibidores de hidroxilase | |
| US10085986B2 (en) | Pyrimidinone compounds and their use | |
| CA2208174A1 (en) | Squalene synthetase inhibitors | |
| OA10204A (en) | Squalene synthetase inhibitors | |
| US20050096335A1 (en) | Heteroaryl - fused nitrogen heterocycles as therapeutic agents | |
| US20110098324A1 (en) | Prolyl hydroxylase inhibitors | |
| CN1040755C (zh) | 杂环化合物的制备方法 | |
| SK8972002A3 (en) | Substituted 8-arylquinoline phosphodiesterase-4 inhibitors | |
| JP4402176B2 (ja) | 新規アミド化合物及びこれを含有する医薬 | |
| KR19990014070A (ko) | 파네실 전이효소 저해활성을 갖는 히단토인 유도체 | |
| EP3423467B1 (en) | New difluoroketamide derivatives as htra1 inhibitors | |
| AU2011224417B2 (en) | 4,4-disubstituted piperidine derivatives useful as inhibitors of dipeptidyl peptidase-1 (DPP-1) | |
| JP4647726B2 (ja) | 新規なアニリド化合物及びこれを含有する医薬 | |
| US6605604B1 (en) | Carboxylic and hydroxamic acid compounds inhibiting metalloproteases, method for preparing same and pharmaceutical compositions containing them | |
| EP3504197B1 (en) | New trifluoromethylpropanamide derivatives as htra1 inhibitors | |
| HK40077414A (en) | Pyrimidine formamide compound and use thereof | |
| JPH06239859A (ja) | アンギオテンシンii拮抗作用を有する環状化合物およびその用途 | |
| HK1130671B (en) | Prolyl hydroxylase inhibitors | |
| HK1122552B (en) | Heteroaryl-substituted amides comprising an unsaturated or cyclic linker group, and their use as pharmaceuticals | |
| HK1122552A1 (en) | Heteroaryl-substituted amides comprising an unsaturated or cyclic linker group, and their use as pharmaceuticals |